Mechanical heart valve patients can manage oral anticoagulant therapy themselves

被引:37
作者
Christensen, TD [1 ]
Andersen, NT
Attermann, J
Hjortdal, VE
Maegaard, M
Hasenkam, JM
机构
[1] Aarhus Univ Hosp, Dept Cardiothorac & Vasc Surg, Skejby Sygehus, DK-8200 Aarhus N, Denmark
[2] Aarhus Univ Hosp, Skejby Sygehus, Inst Expt Clin Res, DK-8200 Aarhus, Denmark
[3] Aarhus Univ, Dept Biostat, DK-8000 Aarhus C, Denmark
关键词
prosthetic heart valve; oral anticoagulant therapy; self-management; international normalized ratio; complications;
D O I
10.1016/S1010-7940(02)00817-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Thromboembolism and anticoagulant related bleeding are still the most common complications in mechanical heart valve patients. Management of the oral anticoagulant therapy is therefore a key determinant for these clinical complications. We hypothesize that patients selected to self-managed oral anticoagulant therapy have a better treatment quality than patients in conventional oral anticoagulant therapy. The aim of this study was to assess the time within the therapeutic International Normalized Ratio (INR) target range and the incidence of clinical complications in our group of patients, and compare these data with published data on conventional management. Methods: Mechanical heart valve patients (N = 94) with a mean age of 47.6 years (range 4.2-76.6 years) were trained in home blood analysis of INR using a CoaguChek(R) home coagulometer and coumarin dosage adjustment. After training, the patients were followed by weekly INR measurements. The therapeutic range was a target INR +/-0.5. The indications for initiating oral anticoagulant therapy were: aortic valve (N = 62), mitral valve (N = 29), tricuspid valve (N = 1) and multiple valves (N = 2). Results: The mean observation time was 2.1 years (range 0.04-6.2 years), and the total number of patient-years was 197. The patients were within the therapeutic INR target range for a median of 76.0% (range 32.1-100.0%) of the time. There were two major thromboembolic events and five major bleedings events, comprised of two deep vein thromboses (both in the same patient), four episodes of epistaxis and one case of gastrointestinal bleeding. All the events required short hospitalization, and after treatment all the patients were discharged from the hospital without any sequelae or other complications. Using published work as references the expected number of major thromboembolic and bleeding complications in conventional management was four and 12, respectively. Conclusions: Self-management of oral anticoagulant therapy provides a good treatment quality for mechanical heart valve patients. We therefore consider self-management of oral anticoagulant therapy as an equally as good or potentially better treatment option for selected patients compared to conventional management. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:292 / 298
页数:7
相关论文
共 25 条
[1]   PATIENT SELF-MANAGEMENT OF ORAL ANTICOAGULATION GUIDED BY CAPILLARY (FINGERSTICK) WHOLE-BLOOD PROTHROMBIN TIMES [J].
ANSELL, J ;
HOLDEN, A ;
KNAPIC, N .
ARCHIVES OF INTERNAL MEDICINE, 1989, 149 (11) :2509-2511
[2]   Evolving models of warfarin management: Anticoagulation clinics, patient self-monitoring, and patient self-management [J].
Ansell, JE ;
Hughes, R .
AMERICAN HEART JOURNAL, 1996, 132 (05) :1095-1100
[3]   LONG-TERM PATIENT SELF-MANAGEMENT OF ORAL ANTICOAGULATION [J].
ANSELL, JE ;
PATEL, N ;
OSTROVSKY, D ;
NOZZOLILLO, E ;
PETERSON, AM ;
FISH, L .
ARCHIVES OF INTERNAL MEDICINE, 1995, 155 (20) :2185-2189
[4]   Precision of patients' measurements of the international normalized ratio (INR) using a patient operated whole blood home coagulometer [J].
Attermann, J ;
Kynde, K ;
Hasenkam, JM .
THROMBOSIS RESEARCH, 1998, 92 (06) :287-291
[5]   OPTIMAL ORAL ANTICOAGULANT-THERAPY IN PATIENTS WITH MECHANICAL HEART-VALVES [J].
CANNEGIETER, SC ;
ROSENDAAL, FR ;
WINTZEN, AR ;
VANDERMEER, FJM ;
VANDENBROUCKE, JP ;
BRIET, E .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (01) :11-17
[6]   THROMBOEMBOLIC AND BLEEDING COMPLICATIONS IN PATIENTS WITH MECHANICAL HEART-VALVE PROSTHESES [J].
CANNEGIETER, SC ;
ROSENDAAL, FR ;
BRIET, E .
CIRCULATION, 1994, 89 (02) :635-641
[7]  
Christensen TD, 2001, SCAND CARDIOVASC J, V35, P107
[8]   Self-management of oral anticoagulation in children with congenital heart disease [J].
Christensen, TD ;
Attermann, J ;
Hjortdal, VE ;
Maegaard, M ;
Hasenkam, JM .
CARDIOLOGY IN THE YOUNG, 2001, 11 (03) :269-276
[9]  
Cosmi B, 2000, HAEMATOLOGICA, V85, P826
[10]   Oral anticoagulation self-management and management by a specialist anticoagulation clinic:: a randomised cross-over comparison [J].
Cromheecke, ME ;
Levi, M ;
Colly, LP ;
de Mol, BJM ;
Prins, MH ;
Hutten, BA ;
Mak, R ;
Keyzers, KCJ ;
Büller, HR .
LANCET, 2000, 356 (9224) :97-102